Additionally, the expression of novel biomarkers of AKI, such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1), increase in the urine and plasma [7]. The gene discussed is LCN2; the disease is acute kidney injury.